VPIM
KYNB

Vanguard Personalized Indexing Management’s Kyntra Bio KYNB Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,781
Closed -$13.8K – 1977
2025
Q1 		$13.8K Buy
1,781
+292
+20% +$3.5K ﹤0.01% 1810
2024
Q4 		$19.7K Buy
1,489
+966
+185% +$8.98K ﹤0.01% 1767
2024
Q3 		$5.22K Buy
523
+103
+25% +$1.55K ﹤0.01% 1770
2024
Q2 		$9.36K Buy
+420
New +$13K ﹤0.01% 1684

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Personalized Indexing Management's KYNB Position: Q2 2025 in Review

Vanguard Personalized Indexing Management sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 1,781 shares — an estimated $13.8K sold.

Vanguard Personalized Indexing Management first reported a position in KYNB in Q2 2024 and held it in 4 quarters. The position peaked at $19.7K in Q4 2024. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • Vanguard Personalized Indexing Management reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 1,781 Kyntra Bio shares in Q2 2025, an estimated $13.8K.
  • Vanguard Personalized Indexing Management first reported a position in Kyntra Bio in Q2 2024 and held it in 4 quarters.
  • Vanguard Personalized Indexing Management's Kyntra Bio position peaked at $19.7K in Q4 2024.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2025, filed 25 Jul 2025.